NewsDialy
The person who sets a drug company's clinical strategy and oversees how patient trials are designed is called the chief medical officer.
Rigel Pharmaceuticals has filled that seat, hiring Alison Hannah as executive vice president and chief medical officer. She held the same combined title at CytomX Therapeutics before joining Rigel.
What the title carries "Chief medical officer" is the executive responsible for the medical and scientific direction of a drug company's development programs.
That means deciding how trials are structured and what outcomes they are powered to detect. Get those design calls wrong early and the data may not answer the right question years later.
Keep reading